Early intervention is essential to treating neuropathy in those with prediabetes.
All articles by John Schieszer, MA
Induced pluripotent stem cells offer a new way to study insulin resistance and other metabolic disorders in humans.
During the past 50 years, diabetes research and management has come a long way, although there is still work to be done.
Activity in certain brain regions of teenagers with type 1 diabetes was increased or decreased with hyperglycemia and hypoglycemia.
PE0139, a super long-acting basal insulin, and PB1023, a weekly GLP-1 receptor agonist, may lead to novel approach to treating diabetes.
Unsupervised closed loop insulin delivery is safe and feasible in the home setting in teens with type 1 diabetes.
Adding liraglutide to insulin in a closed loop system may reduce postprandial hyperglycemia as well as insulin requirements, compared with insulin monotherapy.
Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.
Food insecurity has an impact on glycemic control and vegetable consumption in Latino patients with diabetes.
GLP-1 receptor agonist may be able to reduce glycemic variability rather than a prandial insulin.